GenMark Diagnostics (GNMK) Tops Q4 EPS by 6c

GenMark Diagnostics (NASDAQ: GNMK) reported Q4 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $13.2 million versus the consensus estimate of $12.3 million.

For earnings history and earnings-related data on GenMark Diagnostics (GNMK) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• BTC Digital closes $7M private placement to build Georgia AI data center
• Abivax reports Phase 3 maintenance trial results for obefazimod